Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Distinct Healthcare Closes $40 Million Round for China Clinics

publication date: Aug 28, 2017

Distinct Healthcare of China closed a $40 million C funding round to support its chain of China medical clinics. Distinct operates 20 clinics in six China cities, mostly in Southern China and Hong Kong. It partners with established MDs, who either have worked or continue to work at large public hospitals. The company helps the doctors open new clinics, and then provides administrative, back-end and infrastructure support. The C round included long-time Distinct supporter Matrix Partners China along with Tiantu Capital, China International Capital, Qianhai Fund of Funds, and Shuimu Fund. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital